Prognostic values of novel biomarkers in patients with AL amyloidosis

As cardiac involvement is the most important prognostic marker in light-chain amyloidosis (AL), revised Mayo staging for AL incorporated N-terminal pro-brain natriuretic peptide (NTproBNP) and troponin T (TnT). However, prognostic value of novel biomarkers, such as soluble suppression of tumorigenic...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Darae, Lee, Ga Yeon, Choi, Jin-Oh, Kim, Kihyun, Kim, Seok Jin, Ju, Eun-Seon, Jeon, Eun-Seok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704139/
https://www.ncbi.nlm.nih.gov/pubmed/31434944
http://dx.doi.org/10.1038/s41598-019-48513-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6704139/
https://www.ncbi.nlm.nih.gov/pubmed/31434944
http://dx.doi.org/10.1038/s41598-019-48513-6

Ejemplares similares